SDGR Schrodinger
- 24.440
- +0.470+1.96%
- 24.440
- 0.0000.00%
Schrodinger News
Craig-Hallum Remains a Buy on Schrodinger (SDGR)
Moderna and OpenAI in Pact to Fast-track Drug Development
R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
Schrödinger (NASDAQ:SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its first quarter 2024 financial results on Wednesday, May 1, 2024,
Institutional Owners May Consider Drastic Measures as Schrödinger, Inc.'s (NASDAQ:SDGR) Recent US$69m Drop Adds to Long-term Losses
Key Insights Given the large stake in the stock by institutions, Schrödinger's stock price might be vulnerable to their trading decisions The top 10 shareholders own 51% of the company Using data
Top Buy-rated Stocks and Sell-rated Stocks Within Health Care - Citi
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA) and Schrodinger (SDGR)
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
13 Best Stocks to Buy and Hold According to Bill Gates' Portfolio
In this article, we will be taking a look at the 13 best stocks to buy and hold according to Bill Gates' Portfolio.
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
Schrödinger, Inc. (NASDAQ:SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today presented the discovery of SGR-1505, its MALT1 inhibitor, during the
Schrdinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Schrödinger, Inc. (NASDAQ:SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on March 15, 2024, the company granted (i) non-statutory
Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys?
High Conviction Stocks With U.S. Productivity Opportunities Due to AI - MS
Morgan Stanley listed high conviction stocks with U.S. productivity opportunities thanks to artificial intelligence, as companies have been focusing on efficiency gains.
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Schrodinger Price Target Cut to $39.00/Share From $47.00 by Citigroup
Schrodinger Price Target Cut to $39.00/Share From $47.00 by Citigroup
Critical Insights From Schrodinger Analyst Ratings: What You Need To Know
Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Schrodinger (NASDAQ:SDGR) in the last three months.The table below provides a snapshot of their
Schrodinger Is Maintained at Neutral by Goldman Sachs
Schrodinger Is Maintained at Neutral by Goldman Sachs
Express News | Goldman Sachs Maintains Neutral on Schrodinger, Lowers Price Target to $26
Need To Know: Analysts Just Made A Substantial Cut To Their Schrödinger, Inc. (NASDAQ:SDGR) Estimates
The analysts covering Schrödinger, Inc. (NASDAQ:SDGR) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Both revenue
Analysis
Price Target
No Data
